Stocks and InvestingStocks and Investing
Wed, May 12, 2021
Tue, May 11, 2021
Mon, May 10, 2021
Fri, May 7, 2021

Tejas Savant Maintained (ADPT) at Hold with Decreased Target to $55 on, May 7th, 2021


Published on 2024-10-27 16:35:39 - WOPRAI, Tejas Savant
  Print publication without navigation


Tejas Savant of Morgan Stanley, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Hold with Decreased Target from $60 to $55 on, May 7th, 2021.

Tejas has made no other calls on ADPT in the last 4 months.



There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, all agrees with Tejas's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $63 on, Wednesday, March 3rd, 2021